Pre-earnings options volume in Pacira is normal with calls leading puts 3:1. Implied volatility suggests the market is anticipating a move near 27.4%, or $5.41, after results are released. Median move over the past eight quarters is 3.3%.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCRX:
- Pacira (PCRX) Q2 Earnings Cheat Sheet
- Pacira negative patent ruling most likely outcome, says JPMorgan
- CMS proposes new reimbursement for Exparel in outpatient surgical enviroments
- Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical Environments Beginning January 1, 2025
- Intuit initiated, Charter downgraded: Wall Street’s top analyst calls
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue